Steven George Hughes, Chief Medical Officer at Avidity Biosciences, Inc. (RNA), sold 2,373 shares at $72.23 ($171K) on 2026-01-07, disclosed to the SEC on 2026-01-09.
Scheduled sale ($171k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RNA | SELL | 2025-09-23 | $179K | — | Filing → |
| RNA | SELL | 2025-09-17 | $140K | — | Filing → |
| RNA | SELL | 2025-08-22 | $205K | — | Filing → |